Last reviewed · How we verify
Aspartame/MSG Detox (MALTODEXTRIN)
At a glance
| Generic name | MALTODEXTRIN |
|---|---|
| Sponsor | Deseret Biologicals, Inc. |
| Drug class | Standardized Chemical Allergen [EPC] |
| Therapeutic area | Pain |
| Phase | FDA-approved |
Approved indications
- headache
- dizziness
- mood changes
- vomiting
- nausea
- abdominal cramps
- abdominal pain
- fatigue
- weakness
Common side effects
Key clinical trials
- Effect of Bifidobacterium Animalis Subsp. Lactis Bi66 Supplementation on Gut Function in Healthy Adults (NA)
- The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. (NA)
- Effects of a 6-months Fiber- and Polyphenol-rich Diet on Brain Inflammatory Processes in Perimenopausal Women Living With Overweight or Obesity (NA)
- Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation (PHASE2)
- Effects of Sodium Bicarbonate on Endurance Performance (NA)
- Effect of the Combination of Nitrate and Caffeine on Critical Power In Trained Male Cyclists (NA)
- Short Term Choline and Cardiovascular Health (NA)
- Effect of L. Reuteri LM1063 on Sleep Health Improvement (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aspartame/MSG Detox CI brief — competitive landscape report
- Aspartame/MSG Detox updates RSS · CI watch RSS
- Deseret Biologicals, Inc. portfolio CI